Natriumoksibaatti Kalceks (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoksibaatti Kalceks, is a GABA_B receptor agonist presented as an oral solution for oral use. It treats narcolepsy with cataplexy in adults by improving nocturnal sleep quality and reducing cataplexy episodes. GNH USA supplies Natriumoksibaatti Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sodium Oxybate acts on the central nervous system to address sleep‑wake disorders, primarily narcolepsy with cataplexy. - Narcolepsy with cataplexy: reduces daytime sleepiness and the frequency of cataplexy attacks. - Excessive daytime sleepiness associated with narcolepsy: enhances wakefulness and functional alertness. - Nighttime sleep fragmentation in narcolepsy: promotes slow‑wave sleep and consolidates nocturnal rest.

Sodium Oxybate may cause a range of adverse reactions.

Common Side Effects: - Nausea - Headache - Dizziness - Vomiting - Enuresis (nighttime urination) - Insomnia

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Seizures - Allergic reactions (rash, angioedema) - Suicidal ideation or behavior - Abuse or dependence potential

Sodium Oxybate requires careful monitoring due to its central nervous system effects. - Avoid use in patients with severe respiratory disorders: risk of respiratory depression. - Monitor for signs of abuse or dependence: controlled substance considerations. - Assess renal function before initiation: drug is renally excreted. - Do not combine with other CNS depressants: may increase sedation and respiratory risk. - Pregnancy and breastfeeding: safety not established; avoid unless benefits outweigh risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Sodium Oxybate can interact with several medication classes, requiring dose adjustments or avoidance.

Major Interactions (Avoid): - Alcohol: can cause severe sedation and respiratory depression. - Other CNS depressants (e.g., benzodiazepines, opioids): additive respiratory depression. - Concurrent use with other GABA_B agonists: excessive CNS depression.

Moderate Interactions (Monitor Closely):\n- Antihypertensives: may enhance hypotensive effects. - Diuretics: can affect sodium balance and fluid status. - Anticonvulsants: may alter seizure threshold or drug levels.